Use of anti-psychotic medication in care homes
Terms of reference
The use of anti-psychotic medication in care home settings, and the ways in which its inappropriate use could be reduced, including the consideration of:
the availability of data on the prescribing of anti-psychotics in care homes, to understand prevalence and patterns of use;
prescribing practices, including implementation of clinical guidance and medication reviews;
provision of alternative (non-pharmacological) treatment options;
training for health and care staff to support the provision of person-centred care for care home residents living with dementia;
identifying best practice, and the effectiveness of initiatives introduced so far to reduce inappropriate prescribing of anti-psychotics;
use of anti-psychotic medication for people with dementia in other types of care settings.
The response to this consultation has now been submitted. Please contact the Consultation Response Team ([email protected]) if you have any related queries.